Milestone Historical Income Statement
| MIST Stock | USD 1.85 0.01 0.54% |
Historical analysis of Milestone Pharmaceuticals income statement accounts such as Discontinued Operations of 0.0 can show how well Milestone Pharmaceuticals performed in making a profits. Evaluating Milestone Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Milestone Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Milestone Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Milestone Pharmaceuticals is a good buy for the upcoming year.
Milestone |
About Milestone Income Statement Analysis
Milestone Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Milestone Pharmaceuticals shareholders. The income statement also shows Milestone investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Milestone Pharmaceuticals Income Statement Chart
Add Fundamental
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Milestone Pharmaceuticals minus its cost of goods sold. It is profit before Milestone Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Milestone Pharmaceuticals. It is also known as Milestone Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Milestone Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Milestone Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.At this time, Milestone Pharmaceuticals' Interest Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 153.2 K in 2024, whereas Selling And Marketing Expenses is likely to drop slightly above 8 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 220K | 1.3M | 3.5M | 3.7M | Net Interest Income | 220K | 1.3M | 1.8M | 1.2M |
Milestone Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Milestone Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.